Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!
View the family homepage Submit Your Research
ASGCT members receive online subscriptions to the Molecular Therapy journals to stay up to date on the latest research in the field. Here's how to claim your subscription:
Sign into your ASGCT account.
Navigate to the Membership Dashboard.
Click on the Molecular Therapy link.
Claim Your Subscription
MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.
MTMCD focuses on advances in cell and gene therapy and how they are translated and applied in the clinical setting.
MTNA publishes top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease.
MTO focuses on the development and testing of cancer therapies in pre-clinical and clinical settings, and provides a unique forum for work in the burgeoning fields of biologic cancer therapies including viral, bacterial, cellular, and gene therapy.
Learn more about and submit your research to any of the four journals.
Contact the editors-in-chief of each journal as well as Cell Press communications and advertising staff here.
Want to request permission to use information in Molecular Therapy? Here's how to submit a request.
Read Molecular Therapy's ethical statements on authorship, dual submission, competing interests, inclusion and diversity, and more.
Sept. 25-26, 2025 | Washington, D.C.
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico